Kronos Bio Inc.

NASDAQ: KRON · Real-Time Price · USD
0.88
0.01 (1.49%)
At close: Jun 20, 2025, 9:43 AM

Kronos Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
9.85M 6.29M n/a n/a
Cost of Revenue
n/a n/a 4.46M 4.08M
Gross Profit
9.85M 6.29M -4.46M -4.08M
Operating Income
-92.89M -121.83M -137.12M -151.4M
Interest Income
6.81M 9.16M 3.91M 320K
Pretax Income
-86.08M -112.67M -133.2M -151.08M
Net Income
-86.08M -112.67M -129.29M -149.1M
Selling & General & Admin
24.62M 41.74M 43.4M 38.49M
Research & Development
48.66M 86.38M 93.72M 112.9M
Other Expenses
29.45M n/a n/a n/a
Operating Expenses
102.73M 128.12M 137.12M 151.4M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
102.73M 128.12M 137.12M 151.4M
Income Tax Expense
n/a n/a -3.91M -1.98M
Shares Outstanding (Basic)
60.07M 57.74M 56.2M 54.75M
Shares Outstanding (Diluted)
60.07M 57.74M 56.2M 54.75M
EPS (Basic)
-1.43 -1.95 -2.3 -2.72
EPS (Diluted)
-1.43 -1.95 -2.3 -2.72
EBITDA
-61.72M -119.69M -128.74M -147M
EBIT
-63.43M -121.83M -137.12M -151.08M
Depreciation & Amortization
1.72M 2.14M 4.46M 4.08M